These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 168161)
1. Antibodies to Epstein-Barr virus-associated nuclear antigen and to other viral and non-viral antigens in Hodgkin's disease. Rocchi G; Tosato G; Papa G; Ragona G Int J Cancer; 1975 Aug; 16(2):323-8. PubMed ID: 168161 [TBL] [Abstract][Full Text] [Related]
2. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens. Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984 [TBL] [Abstract][Full Text] [Related]
3. An immunofluorescence technique with counterstain on fixed cells for the detection of antibodies to human herpesviruses; antibody patterns in patients with Hodgkin's disease and nasopharyngeal carcinoma. Hilgers F; Hilgers J Intervirology; 1976; 7(6):309-27. PubMed ID: 67099 [TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus infections in Brazil. II. Hodgkin's disease. Evans AS; Carvalho RP; Frost P; Jamra M; Pozzi DH J Natl Cancer Inst; 1978 Jul; 61(1):19-26. PubMed ID: 209202 [TBL] [Abstract][Full Text] [Related]
5. Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity. Berkel AI; Henle W; Henle G; Ersoy F; Sanal O; Klein G; Yeğin O Kroc Found Ser; 1985; 19():287-300. PubMed ID: 2999343 [TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. Ascherio A; Munger KL; Lennette ET; Spiegelman D; Hernán MA; Olek MJ; Hankinson SE; Hunter DJ JAMA; 2001 Dec; 286(24):3083-8. PubMed ID: 11754673 [TBL] [Abstract][Full Text] [Related]
7. The relation between Epstein-Barr virus antibodies and clinical symptomatology and immunodeficiency in patients with Hodgkin's disease. Mochanko K; Fejes M; Breazavscek DM; Suarez A; Bachmann AE Cancer; 1979 Dec; 44(6):2065-70. PubMed ID: 228834 [TBL] [Abstract][Full Text] [Related]
8. A population-based case-control study of EBV and other viral antibodies among persons with Hodgkin's disease and their siblings. Evans AS; Gutensohn NM Int J Cancer; 1984 Aug; 34(2):149-57. PubMed ID: 6088401 [TBL] [Abstract][Full Text] [Related]
9. Increased incidence of IgA antibodies to the Epstein-Barr virus-associated viral capsid antigen and early antigens in patients with chronic lymphocytic leukemia. Dölken G; Bross KJ; Hecht T; Brugger W; Löhr GW; Hirsch FW Int J Cancer; 1986 Jul; 38(1):55-9. PubMed ID: 3013785 [TBL] [Abstract][Full Text] [Related]
10. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease]. Kuljić-Kapulica N Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363 [TBL] [Abstract][Full Text] [Related]
11. Anti-EBV antibody titers in non-Hodgkin lymphomas. Dumont J; Liabeuf A; Henle W; Feingold N; Kourilsky FM Int J Cancer; 1976 Jul; 18(1):14-23. PubMed ID: 181335 [TBL] [Abstract][Full Text] [Related]
12. [Comparative study of anti EBV antibodies in non-Hodgkin's lymphomams and angio-immunoblastic lymphadenopathies (author's transl)]. Dumont J; Liabeuf A; Henle W; Ferchal F; Feingold N; Kourilsky FM Bull Cancer; 1979; 66(4):373-81. PubMed ID: 230873 [TBL] [Abstract][Full Text] [Related]
13. Virus-specific antibodies to Epstein-Barr virus, varicella-zoster virus and rubella virus in renal transplant patients with cytomegalovirus infections. O'Neill HJ; Shirodaria PV J Infect; 1992 May; 24(3):301-9. PubMed ID: 1318341 [TBL] [Abstract][Full Text] [Related]
14. Antibodies to Epstein-Barr virus-specific antigens in patients with hairy-cell leukemia. Sakamoto K; Aiba M; Katayama I; Sullivan JL; Humphreys RE; Purtilo DT Int J Cancer; 1981; 27(4):453-8. PubMed ID: 6268553 [TBL] [Abstract][Full Text] [Related]
15. Lack of correlation between EBV serology and presence of EBV in the Hodgkin and Reed-Sternberg cells of patients with Hodgkin's disease. Enblad G; Sandvej K; Lennette E; Sundström C; Klein G; Glimelius B; Pallesen G Int J Cancer; 1997 Jul; 72(3):394-7. PubMed ID: 9247279 [TBL] [Abstract][Full Text] [Related]
16. Disease-related differences in antibody patterns against EBV-encoded nuclear antigens EBNA 1, EBNA 2 and EBNA 6. Lennette ET; Rymo L; Yadav M; Masucci G; Merk K; Timar L; Klein G Eur J Cancer; 1993; 29A(11):1584-9. PubMed ID: 8217366 [TBL] [Abstract][Full Text] [Related]
17. Longitudinal study of Epstein-Barr virus antibody titers and excretion in pediatric patients with Hodgkin's disease. Lange B; Arbeter A; Hewetson J; Henle W Int J Cancer; 1978 Nov; 22(5):521-7. PubMed ID: 82539 [TBL] [Abstract][Full Text] [Related]
18. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Pallesen G; Hamilton-Dutoit SJ; Rowe M; Young LS Lancet; 1991 Feb; 337(8737):320-2. PubMed ID: 1671232 [TBL] [Abstract][Full Text] [Related]
19. Relationship between clinical stage, histopathology and antibody titers against the second Epstein-Barr virus nuclear antigen (EBNA-2) in non-Hodgkin's lymphoma patients. Masucci G; Mellstedt H; Henle G; Henle W; Rymo L; Masucci MG; Ernberg I; Klein G Int J Cancer; 1989 Jun; 43(6):1017-21. PubMed ID: 2543639 [TBL] [Abstract][Full Text] [Related]